When neighbourhood matters: Tumour microenvironment

Clinical and Translational Oncology

Volumn 11, Issue 2, 2009, Pages 70-74

  Pérez Moreno, Mirna ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

Cancer; Immune cells; Inflammation; Tumor microenvironment

Indexed keywords

CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD VESSEL; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MACROPHAGE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; MICROENVIRONMENT; POLYMORPHONUCLEAR CELL; REGULATORY T LYMPHOCYTE; BIOLOGICAL MODEL; CANCER INVASION; IMMUNOLOGY; METASTASIS; NEOPLASM; PATHOLOGY;

HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 67449098984     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-009-0316-z     Document Type: Article

References (47)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
2. Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119-150
3. de Visser KE, Coussens LM (2006) The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13:118-137
4. de Visser KE (2008) Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both? Cancer Immunol Immunother 57:1531-1539
5. Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357:539-545
6. Burnet FM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13:1-27
7. Schafer M, Werner S (2008) Cancer as an overhealing wound: An old hypothesis revisited. Nat Rev Mol Cell Biol 9:628-638
8. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436-444
9. Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211-217
10. Houghton J, Stoicov C, Nomura S et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568-1571
11. Greten FR, Eckmann L, Greten TF et al (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296
12. Pikarsky E, Porat RM, Stein I et al (2004) NFkappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431:461-466
13. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867
14. DeNardo DG, Johansson M, Coussens LM (2008) Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev 27:11-18
15. Mantovani A, Sica A, Sozzani S et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686
16. Pollard JW (2004) Tumour-educated ma cro phages promote tumour progression and metastasis. Nat Rev Cancer 4:71-78
17. Cursiefen C, Chen L, Borges LP et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040-1050
18. Lucas T, Abraham D, Aharinejad S (2008) Modulation of tumor associated macrophages in solid tumors. Front Biosci 13:5580-5588
19. Curiel T, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942-949
20. Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 196:254-265
21. Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740
22. Coussens LM, Raymond WW, Bergers G et al (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382-1397
23. Guerra C, Schuhmacher AJ, Cañamero M et al (2007) Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11:291-302
24. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540-550
25. Kacinski BM (1995) CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 27:79-85
26. Balkwill F (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13:135-141
27. Arnott CH, Scott KA, Moore RJ et al (2004) Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 23:1902-1910
28. Voronov E, Shouval DS, Krelin Y et al (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 100:2645-2650
29. Trikha M, Corringham R, Klein B, Rossi JF (2003) Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: A review of the rationale and clinical evidence. Clin Cancer Res 9:4653-4665
30. Choy H, Milas L (2003) Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: A rational advance? J Natl Cancer Inst 95:1440-1452
31. Gasparini G, Longo R, Sarmiento R, Morabito A (2003) Inhibitors of cyclo-oxygenase 2: A new class of anticancer agents? Lancet Oncol 4:605-615
32. Jacoby RF, Seibert K, Cole CE et al (2000) The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60:5040-5044
33. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411-423
34. Sipowicz MA, Weghorst CM, Shiao Y-H et al (1997) Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice. Carcinogenesis 18:233-236
35. Cortes Sempere M, Rodríguez Fanjul V, Sánchez Pérez I, Perona R (2008) The role of the NFkappaB signalling pathway in cancer. Clin Transl Oncol 10:143-147
36. Karin M (2008) The IkappaB kinase - a bridge between inflammation and cancer. Cell Res 18:334-342
37. Sur I, Ulvmar M, Toftgard R (2008) The twofaced NF-kappaB in the skin. Int Rev Immunol 27:205-223
38. Perez-Moreno M, Song W, Pasolli HA et al (2008) Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer. Proc Natl Acad Sci U S A 105:15399-15404
39. Hui L, Bakiri L, Stepniak E, Wagner EF (2007) p38alpha: A suppressor of cell proliferation and tumorigenesis. Cell Cycle 6:2429-2433
40. Karin M (2004) Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs. Ann Rheum Dis 63[Suppl 2]:iI62-ii64
41. Arnott CH, Scott KA, Moore RJ et al (2002) Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene 21:4728-4738
42. Brown JR, DuBois RN (2004) Cyclooxygenase as a target in lung cancer. Clin Cancer Res 10:4266s-4269s
43. Stack E, DuBois RN (2001) Role of cyclooxygenase inhibitors for the prevention of colorectal cancer. Gastroenterol Clin North Am 30:1001-1010
44. Kessel A, Rosner I, Toubi E (2008) Rituximab: Beyond simple B cell depletion. Clin Rev Allergy Immunol 34:74-79
45. Giraudo E, Inoue M, Hanahan D (2004) An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114:623-633
46. Robinson SC, Scott KA, Wilson JL et al (2003) A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 63:8360-8365
47. Naugler WE, Karin M (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18:19-26